[IMRX] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[IMRX] Immuneering Corporation
Announcement Date
03-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -101.15%
YoY- -5.74%
Quarter Report
IMRX's Result
IMRX's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 0 -94,419 0 94,419 0 0 38 -
PBT -14,308 -15,084 -12,595 -12,189 -13,604 -13,246 -12,844 7.45%
Tax -0 -755 -13,912,372 -1,139 -1,075,403 -740 -344 -
NP -14,308 -15,083 -12,595 -12,189 1,061,799 -12,506 -12,501 9.40%
Tax Rate - - - - - - - -
Total Cost 14,308 -79,336 12,595 106,608 -1,061,799 12,506 12,539 9.18%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin 0.00 15.98 0.00 -12.91 0.00 -2,742,434.65 -32,570.38 -
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS -0.49 -0.52 -0.43 -0.43 40.16 -0.47 -0.47 2.81%
EPS Diluted -0.49 -0.52 -0.43 -0.43 40.16 -0.47 -0.47 2.81%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.